ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,171,000 | +713.1% | 9,021,232 | +349.4% | 0.00% | – |
| Q1 2020 | $390,000 | +51.8% | 2,007,529 | +70.2% | 0.00% | – |
| Q4 2019 | $257,000 | +133.6% | 1,179,517 | +146.6% | 0.00% | – |
| Q3 2019 | $110,000 | -6.0% | 478,278 | +0.3% | 0.00% | – |
| Q2 2019 | $117,000 | -48.7% | 476,626 | +0.5% | 0.00% | – |
| Q1 2019 | $228,000 | +24.6% | 474,374 | +0.4% | 0.00% | – |
| Q4 2018 | $183,000 | -47.4% | 472,514 | +0.5% | 0.00% | – |
| Q3 2018 | $348,000 | +15.6% | 470,206 | +0.1% | 0.00% | – |
| Q2 2018 | $301,000 | +27.0% | 469,578 | -27.6% | 0.00% | – |
| Q1 2018 | $237,000 | -45.8% | 648,558 | -1.3% | 0.00% | – |
| Q4 2017 | $437,000 | +22.1% | 657,324 | +5.4% | 0.00% | – |
| Q3 2017 | $358,000 | -51.4% | 623,394 | +3.2% | 0.00% | – |
| Q2 2017 | $737,000 | -30.4% | 604,130 | -13.9% | 0.00% | – |
| Q1 2017 | $1,059,000 | – | 701,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |